Cargando…
Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
Parkinson’s disease (PD) is a common age-associated neurodegenerative motor disorder, which is mainly caused by dopaminergic neuron loss in the substantia nigra. This study aimed to evaluate the function and the underlying molecular mechanism of itaconate in PD. PD models were established in vivo an...
Autores principales: | Sun, Guoqing, Zhang, Rui, Liu, Chengxiao, Meng, Wenjun, Pang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496935/ https://www.ncbi.nlm.nih.gov/pubmed/36138991 http://dx.doi.org/10.3390/brainsci12091255 |
Ejemplares similares
-
Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
por: Zhang, Bei, et al.
Publicado: (2019) -
Itaconate confers tolerance to late NLRP3 inflammasome activation
por: Bambouskova, Monika, et al.
Publicado: (2021) -
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
por: Kou, Liang, et al.
Publicado: (2022) -
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
por: Hooftman, Alexander, et al.
Publicado: (2020) -
Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome
por: Rong, Shikuo, et al.
Publicado: (2019)